We have been providing whole human genome sequencing services for over 10 years to support researchers and companies all over the world with their human genome sequencing needs.
Please get in touch for a no-obligation quote or discussion about your project.
BGI’s human whole genome sequencing (WGS) service provides comprehensive coverage of an individual’s complete genome at a single time. WGS can be used to obtain a high-resolution, base-by-base view of the genome, capture both large and small variants that might otherwise be missed and identify potential causative variants for further follow-on studies of gene expression and regulation mechanisms.
At BGI, we have been providing commercial WGS services for over 10 years and have processed over 1,000,000 samples for partners across the world. Our mission is to provide a fast and affordable service with industry leading data quality.
Regular Samples:
- Intact genomic DNA ≥ 1μg
- Concentration ≥ 12.5ng/ μl
- Volume 15 μl
Low Input Samples:
- Intact genomic DNA ≥ 200ng
- Concentration ≥ 2.5 ng/ μl
- Volume 15 μl
BGI Human Whole Genome Sequencing services are typically executed with our proprietary DNBSEQ™ NGS technology platform, for great sequencing data at the lowest cost in the industry.
DNBSEQ™ is a proprietary sequencing technology, first developed by MGI's Complete Genomics subsidiary in Silicon Valley, and can offer advantages in terms of lower amplification error rates and much lower duplication rates for some sequencing applications. In addition, studies have shown the index hopping rate in DNBSEQ™ platforms can be much lower when compared to that of other platforms.
CopyrightⒸ BGI 2025. All rights reserved. All product names, logos, and brands are property of their respective owners. All company, product and service names used in this email are for identification purposes only. Use of these names, logos, and brands does not imply endorsement. This email contains information on services or products targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information, which may not comply with any legal process, regulation, registration, or usage in the country of your origin. We hereby disclose that this email communication is for commercial purposes. Unless otherwise informed, certain sequencers and sequencing reagents are not available in selected countries or regions. Please get in touch with a representative for regional availability. The company reserves the right of final interpretation.